Equitybee 22-97033 amends offering statement for fundraising
Equitybee 22-97033 has amended its offering statement, highlighting its ongoing fundraising efforts in the private equity sector. Details from the SEC filing.
Delaware Group Equity Funds II Appoints New Sub-Advisor
Delaware Group Equity Funds II announces Macquarie Investment Management as sub-advisor for its Nomura Value Fund, effective immediately.
Barclays Bank announces $4.5 million AutoCallable Notes
Barclays Bank PLC files pricing supplement for $4.5 million in AutoCallable Notes linked to major stock indices, enhancing its financial offerings.
NAPCO Security Technologies Files Proxy Statement for Meeting
NAPCO Security Technologies has filed a definitive proxy statement ahead of its annual meeting on December 10, 2026, outlining key agenda items.
Ivy Variable Insurance Portfolios Names New Sub-Advisor
Ivy Variable Insurance Portfolios appoints Macquarie Investment Management as sub-advisor for Nomura VIP Value Series, set for name change in 2026.
NAPCO Security Technologies files preliminary proxy statement
NAPCO Security Technologies files a preliminary proxy statement, signaling upcoming shareholder meetings and governance changes.
LVC Fund II Launches New Offering of $286,831
LVC Fund II, Oct 2026 a Series of CGF2026 LLC files for a new offering totaling $286,831 under Rule 506(b), targeting accredited investors.
NAPCO Security Technologies releases annual report
NAPCO Security Technologies, Inc. shares its annual report, highlighting financial performance and strategies in the communications equipment sector.
Delaware Group Equity Funds II appoints new sub-advisor, changes name
Delaware Group Equity Funds II announces new sub-advisor and name change for Nomura Value Fund, reflecting strategic shifts in investment approach.
Wells Fargo Finance files pricing supplement for new notes
Wells Fargo Finance LLC files a pricing supplement for Medium-Term Notes linked to the S&P 500, totaling $3,966,000, indicating strategic market positioning.
Ivy Variable Insurance Portfolios Appoints New Sub-Advisor
Ivy Variable Insurance Portfolios names Macquarie Investment Management Global Limited as sub-advisor for Nomura VIP Value Series, effective immediately.
Hyundai Auto Receivables Trust 2026-D Updates Asset-Backed Securities
Hyundai Auto Receivables Trust 2026-D files an update on asset-backed securities, reflecting ongoing activity in the auto loan market.
Chilton Capital Management reveals $3.18B portfolio in 13F-HR
Chilton Capital Management's latest 13F-HR filing shows a portfolio valued at over $3.18 billion, highlighting its investment strategies and market positioning.
Crystal Venture Partners Fund II files new offering under Rule 506(b)
Crystal Venture Partners Fund II, L.P. files a new offering under Rule 506(b), raising $25.3 million as it enters the venture capital landscape.
Arcline Systems announces new private offering under Rule 506(b)
Arcline Systems, Inc. files for a new private offering under Rule 506(b) with $75,000 already sold, signaling investment strategies in tech.
Warm Springs Advisors announces $159.7M in latest 13F-HR filing
Warm Springs Advisors Inc. reveals $159.7 million in holdings in its latest 13F-HR filing, reflecting its investment strategy and market positions.
Hudson Edge Investment Partners reports $727.7M in holdings
Hudson Edge Investment Partners reveals $727.7 million in holdings as of September 30, 2026, highlighting its investment strategy and market position.
Main Street Group files 13F-HR with $444.9 million in holdings
Main Street Group, LTD's latest 13F-HR report reveals $444.9 million in securities, highlighting its investment strategies and market engagement.
Legg Mason Partners Institutional Trust Files Annual Report
Legg Mason Partners Institutional Trust files its annual report, detailing fund performance and expenses for the Western Asset Institutional U.S. Treasury Reserves.
Franklin Templeton increases stake in Contineum Therapeutics
Franklin Templeton, Inc. has reported a 5.2% ownership in Contineum Therapeutics, Inc., marking a significant investment in the pharmaceutical sector.